David Shlaes News Today

Forget COVID-19, monkeypox and other viruses for the moment and consider another threat troubling infectious disease specialists: common urinary tract infections, or UTIs, that lead to emergency room visits and

Antimicrobial-resistant organisms surged during COVID and the threat looms large, but there's still too few to create demand for new antibiotics.

Forget covid-19, monkeypox, and other viruses for the moment and consider another threat troubling infectious disease specialists: common urinary tract infections, or UTIs, that lead to emergency room visits and even hospitalizations because of the failure of oral antibiotics.

Existing drugs still treat most infections. But that has discouraged investment in new drugs that will be needed when — not if —the old ones fail.

Existing drugs still treat most infections. But that has discouraged investment in new drugs that will be needed when — not if —the old ones fail.

Existing drugs still treat most infections. But that has discouraged investment in new drugs that will be needed when — not if —the old ones fail.